News Roundup for February 04, 2022

1A

NPR

News

4.3 • 4.5K Ratings

🗓️ 4 February 2022

⏱️ 88 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

The situation at the border between Ukraine and Russia continues to develop. U.S. troops were sent to Poland and Romania as peace talks between Russia, the U.S., and other NATO member nations stalled.

Pharmaceutical giant Pfizer is submitting a request to the FDA asking for emergency authorization for use of its COVID-19 vaccine in children under the age of 5.

Meanwhile, Russia and the U.S. continue to send supplies to forces positioned around the Russian border with Ukraine.

The U.S. has sent 500 tons of defensive equipment to the region so far. Russia has sent stores of blood to the border.

The diplomacy surrounding the potential Russia/Ukraine conflict has been fraught. Russian President Vladimir Putin accused the U.S. of trying to goad his country into conflict.
Hungarian Prime Minister Viktor Orbán visited Moscow this week. He returned from his trip calling Russian demands of NATO reasonable and sanctions pointless.

We get into all this and more during the News Roundup.

Want to support 1A? Give to your local public radio station and subscribe to this podcast. Have questions? Find us on Twitter @1A.

Transcript

Click on a timestamp to play from that location

0:00.0	Hey, it's Jen. Just a quick heads up before we start the show.
0:03.8	The news is rapidly developing and things may have changed by the time you hear this episode.
0:09.0	For the latest news tune into your public radio station and follow updates at npr.org.
0:22.1	This is the 1A podcast. I'm Sarah McCammon in for Gen White. Let's jump into the news roundup.
0:27.7	Today, we're starting a broad. The Biden administration is facing questions about a huge raid in Syria and a tense standoff in Ukraine.
0:36.0	What kinds of answers are they giving? We'll get into that. Plus, the parents of young children are waiting and watching as Pfizer
0:42.7	submits an authorization request for a COVID vaccine to treat kids under age five.
0:47.7	And former President Trump is already making some big promises about what he'll do if he's reelected.
0:53.7	So let's bring in today's guest, Cheryl Gastolberg is a Washington correspondent covering health policy for the New York Times. Cheryl, always a pleasure.
1:01.7	Thank you for having me. Raphael Bernal is a staff writer with the Hill. Raphael, thanks for joining us.
1:07.7	Thanks for having me back. And Jeff Mason is the White House correspondent for Reuters. Hi, Jeff. Welcome back.
1:13.7	Hi, thanks for having me. We are learning more about the nighttime raid that left the leader of ISIS dead in Northwest Syria on Wednesday.
1:21.7	President Biden says Abu Ibrahim al-Hashmi al-Kharashi detonated a bomb during a raid on his safe house by U.S. Special Forces, killing himself and others.
1:31.7	At least 13 people died, including six children and four women.
1:35.7	Last night's operation took a major terrorist leader off the battlefield and it sent a strong message to terrorists around the world.
1:43.7	We will come after you and find you.
1:47.7	Jeff, I want to start with you first of all, what do we know about this ISIS leader who was al-Kharashi first of all?
1:53.7	Well, he succeeded the last ISIS leader who had also been killed or by detonating explosives actually in a similar way when U.S. forces approached him during the Trump administration.
2:07.7	So he was the successor to that. He was leading the organization, which I think it's important to note, was severely depleted in the last several years.
2:19.7	At one point, it sort of had rained over a large swath of territory in the Middle East and all of that had largely been taken away.
2:29.7	So a depleted organization, but nonetheless one that was still a danger and President Biden essentially claiming victory without necessarily using that word yesterday in announcing this raid.
2:43.7	And what do we know about that raid this week that killed him?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.